Lewis and Clark Pharmaceuticals, Inc.

Follow

Organization

Charlottesville, VA, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agon...
- Patent number 9,822,141
- Issue date Nov 21, 2017
- Lewis and Clark Pharmaceuticals, Inc.
- Robert D Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B a...
- Patent number 9,593,118
- Issue date Mar 14, 2017
- Lewis and Clark Pharmaceuticals, Inc.
- Robert D. Thompson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonists
- Patent number 9,067,963
- Issue date Jun 30, 2015
- Lewis and Clark Pharmaceuticals, LLC
- Robert D Thompson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
N-ALKYL 2-(DISUBSTITUTED)ALKYNYLADENOSINE-5-URONAMIDES AS A2A AGONISTS
- Publication number 20190077824
- Publication date Mar 14, 2019
- Lewis and Clark Pharmaceuticals, Inc.
- Robert D. Thompson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
XANTHINE-SUBSTITUTED ALKYNYL CARBAMATES/REVERSE CARBAMATES AS A2B A...
- Publication number 20160297819
- Publication date Oct 13, 2016
- Lewis and Clark Pharmaceuticals, Inc.
- Robert D. Thompson
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks